Bill Texts: NJ A4052 | 2022-2023 | Regular Session

Bill Title: Establishes three-year sickle cell disease pilot program; appropriates $10,200,000.

Spectrum: Strong Partisan Bill (Democrat 24-2)

Status: (Passed) 2024-01-08 - Approved P.L.2023, c.242. [A4052 Detail]

Bill Drafts

RevisionDateFormatSourceView
Amended2023-06-06HTML/TextLinkView
Introduced2022-05-20HTML/TextLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for New Jersey A4052

Supplemental Documents

TitleDescriptionDateFormatSourceView
AnalysisStatement AHE 6/5/23Not AvailPDFLinkView
AnalysisStatement AAP 6/22/23 1RNot AvailPDFLinkView
Fiscal NoteFiscal Estimate 6/26/23; 1RNot AvailPDFLinkView
AnalysisStatement SBA 11/30/23Not AvailPDFLinkView

Social Comments on NJ A4052

feedback